Crossmark

Genetic Clustering of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Patients of Colorectal Origin: KRAS and Not TP53 Cluster Alterations are Associated with Poor Outcomes

Crossref DOI link: https://doi.org/10.1245/s10434-024-15786-9

Published Online: 2024-07-13

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yu, Allen T.

Hanna, David N.

Li, Thomas M.

Sarfaty, Elad

Khajoueinejad, Nazanin

Li, Judy

Golas, Benjamin

Hiotis, Spiros

Labow, Daniel

Sarpel, Umut

Magge, Deepa R.

Cohen, Noah A.
License Information

Text and Data Mining valid from 2024-07-13

Version of Record valid from 2024-07-13
More Information

Article History

Received: 28 March 2024

Accepted: 27 June 2024

First Online: 13 July 2024

Disclosure

: Allen T. Yu, David N. Hanna, Thomas M. Li, Elad Sarfaty, Nazanin Khajoueinejad, Judy Li, Benjamin Golas, Spiros Hiotis, Daniel Labow, Umut Sarpel, Deepa R. Magge, and Noah A. Cohen declare they have no disclosures or competing interests that may be relevant to the contents of this article.

: The study was IRB-approved: IRB# 15-00389-CR003 MSH, IRB #200638 VUMC. All patients provided their consent to participate in the survey.

Document is current

Any future updates will be listed below